Kineret® (anakinra) – PRODUCT INFORMATION

KINERET is a sterile, clear, colorless-to-white, preservative-free solution that comes in a prefilled glass syringe to be administered as a subcutaneous injection daily.  Each prefilled glass syringe contains: 0.67 mL (100 mg) of anakinra in a solution (pH 6.5) containing sodium citrate (1.29 mg), sodium chloride (5.48 mg), disodium EDTA (0.12 mg), and polysorbate 80 (0.70 mg) in Water for Injection, USP.

Indications – Rheumatoid Arthritis
KINERET is indicated for the reduction in signs and symptoms and slowing the progression of structural damage in moderate to severely active rheumatoid arthritis in patients 18 years or older who have failed to respond to one or more DMARDS.  KINERET can be initiated in combination with DMARDS other than tumor necrosis factor (TNF) blocking agents or alone.

For more information and/or complete prescribing information, please visit kineretrx.com.

Kineret is a registered trademark of Amgen Inc.